Real-world Experience with Sofosbuvir-based Regimens for Chronic Hepatitis C, Including Patients with Factors Previously Associated with Inferior Treatment Response

The introduction of sofosbuvir, a direct acting antiviral, has revolutionized the treatment of chronic hepatitis C virus (HCV). Phase 3 clinical trials have demonstrated the efficacy, simplicity, and tolerability of sofosbuvir-based regimens and report high rates of sustained virological response (S...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Hawaii J Med Public Health
Autors principals: Wu, Christina J, Roytman, Marina M, Hong, Leena K, Huddleston, Leslie, Trujillo, Ruby, Cheung, Alvin, Poerzgen, Peter, Tsai, Naoky CS
Format: Artigo
Idioma:Inglês
Publicat: University Clinical, Education & Research Associate (UCERA) 2015
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4582387/
https://ncbi.nlm.nih.gov/pubmed/26793407
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars